Evidence map›Paper›PMID 26938081›Full record

ArticlePLoS computational biology2016

4C-ker: A Method to Reproducibly Identify Genome-Wide Interactions Captured by 4C-Seq Experiments.

Ramya Raviram, Pedro P Rocha, Christian L Müller, Emily R Miraldi, Sana Badri, Yi Fu, Emily Swanzey, Charlotte Proudhon, Valentina Snetkova, Richard Bonneau and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Intronic enhancers of the humanScience advances · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ramya RaviramDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Pedro P RochaDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Christian L MüllerDepartment of Biology, New York University, New York, New York, United States of America.
Emily R MiraldiDepartment of Biology, New York University, New York, New York, United States of America.
Sana BadriDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Yi FuDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Emily SwanzeySkirball Institute, New York University School of Medicine, New York, New York, United States of America.
Charlotte ProudhonDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Valentina SnetkovaDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Richard BonneauDepartment of Biology, New York University, New York, New York, United States of America.
Jane A SkokDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
New York University · USCourant Institute of Mathematical Sciences · USSimons Foundation · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Nanomedicine development center for mechanobiologyPN2EY016586 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2005 to 2014
$23.0M
TRANS-NETWORK PROJECTSU54CA143907 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHIBATA, DARRYL K · 2009 to 2013
$15.2M
REGULATION OF AMINO ACID BIOSYNTHESIS GENES IN PLANTSR01GM032877 · NIGMS · ROCKEFELLER UNIVERSITY · PI CORUZZI, GLORIA · 1985 to 2012
$4.8M
Role Of Nuclear Organization In Protecting Genome Stability During RecombinationR01GM086852 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLUGER, YUVAL, SKOK, JANE AMANDA · 2008 to 2016
$3.8M
Enhancer Driven Gene Regulation During Lymphocyte DevelopmentR01GM112192 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SKOK, JANE AMANDA · 2014 to 2016
$1.6M
A novel role for 53BP1 independent of damage that controls chromatin structureK99GM117302 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROCHA, PEDRO P · 2016 to 2017
$180k
Center for Mechanotransduction and Nanomedicine. (RMI)PN1EY016586 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SHEETZ, MICHAEL PATRICK · 2004 to 2004
$81k
NCI NIH HHS IU54CA143907-01NCI NIH HHS P30 CA016087NCI NIH HHS U54 CA143907NEI NIH HHS EY016586-06NEI NIH HHS PN1 EY016586NEI NIH HHS PN2 EY016586NEI NIH HHS PN2-EY016586NIGMS NIH HHS GM086852NIGMS NIH HHS GM112192NIGMS NIH HHS GM32877-21/22NIGMS NIH HHS K99 GM117302NIGMS NIH HHS R01 GM032877NIGMS NIH HHS R01 GM086852NIGMS NIH HHS R01 GM112192
6 · The paper itself

Abstract

4C-Seq has proven to be a powerful technique to identify genome-wide interactions with a single locus of interest (or "bait") that can be important for gene regulation. However, analysis of 4C-Seq data is complicated by the many biases inherent to the technique. An important consideration when dealing with 4C-Seq data is the differences in resolution of signal across the genome that result from differences in 3D distance separation from the bait. This leads to the highest signal in the region immediately surrounding the bait and increasingly lower signals in far-cis and trans. Another important aspect of 4C-Seq experiments is the resolution, which is greatly influenced by the choice of restriction enzyme and the frequency at which it can cut the genome. Thus, it is important that a 4C-Seq analysis method is flexible enough to analyze data generated using different enzymes and to identify interactions across the entire genome. Current methods for 4C-Seq analysis only identify interactions in regions near the bait or in regions located in far-cis and trans, but no method comprehensively analyzes 4C signals of different length scales. In addition, some methods also fail in experiments where chromatin fragments are generated using frequent cutter restriction enzymes. Here, we describe 4C-ker, a Hidden-Markov Model based pipeline that identifies regions throughout the genome that interact with the 4C bait locus. In addition, we incorporate methods for the identification of differential interactions in multiple 4C-seq datasets collected from different genotypes or experimental conditions. Adaptive window sizes are used to correct for differences in signal coverage in near-bait regions, far-cis and trans chromosomes. Using several datasets, we demonstrate that 4C-ker outperforms all existing 4C-Seq pipelines in its ability to reproducibly identify interaction domains at all genomic ranges with different resolution enzymes.

Indexed as

SoftwareAlgorithmsBase SequenceBinding SitesDNA, CatalyticGenomeMolecular Sequence DataProtein BindingRestriction MappingSequence Analysis, DNADNA, Catalytic

Identifiers

PMID26938081
PMCPMC4777514
OpenAlexW2951733010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.